Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
J Surg Oncol. 2021 Dec;124(7):1014-1021. doi: 10.1002/jso.26606. Epub 2021 Jul 12.
Disparities in esophageal cancer are well-established. The standard treatment for locally advanced esophageal cancer is chemoradiation followed by surgery. We sought to evaluate the association between socioeconomic factors, time to surgery, and patient outcomes.
All patients ≥18 years old diagnosed with T2/3/4 or node-positive esophageal cancer between 2004 and 2016 and who underwent chemoradiation and esophagectomy in the National Cancer Database were included. Multivariable regression was used to assess the association between socioeconomic variables and time to surgery (grouped into <56, 56-84, and 85-112 days).
A total of 12 157 patients were included. Five-year overall survival was 39%, 35%, and 35% for the three groups examined. Postoperative 30- and 90-day mortality was increased in both the 56-84 days to surgery group (odds ratio [OR]: 1.30 and 1.20, respectively) and the 85-112 days group (OR: 1.37 and 1.56, respectively) when compared to <56 days. Patients of a minority race, public insurance, or lower income were more likely to have a longer time to surgery.
Longer time to surgery is associated with increased postoperative mortality and is more common in patients with lower socioeconomic status. Further research exploring reasons for delays to esophagectomy among disadvantaged patients could help target interventions to reduce disparities.
食管癌存在明显的差异。局部晚期食管癌的标准治疗方法是放化疗后再进行手术。我们旨在评估社会经济因素、手术时间与患者预后之间的关系。
本研究纳入了 2004 年至 2016 年间在国家癌症数据库中诊断为 T2/3/4 期或淋巴结阳性食管癌且接受放化疗和食管癌切除术的年龄≥18 岁的所有患者。采用多变量回归评估社会经济变量与手术时间(分为<56、56-84 和 85-112 天)之间的关系。
共纳入 12157 例患者。三组患者的 5 年总生存率分别为 39%、35%和 35%。与<56 天相比,56-84 天和 85-112 天两组的术后 30 天和 90 天死亡率均升高(比值比[OR]:1.30 和 1.20,分别;OR:1.37 和 1.56,分别)。少数民族、公共保险或低收入患者更有可能手术时间较长。
手术时间延长与术后死亡率增加相关,且在社会经济地位较低的患者中更为常见。进一步研究探索弱势患者接受食管癌切除术延迟的原因,可能有助于确定减少差异的干预措施。